NNVC logo

NanoViricides (NNVC) Cash From Investing

Annual CFI

-$156.60 K
-$4900.00-3.23%

June 30, 2024

Summary

Performance

1-Year Change

-3.23%

3-Year Change

+34.42%

5-Year Change

-112.2%

15-Year Change

+5.09%

NNVC Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.09%
NNVC annual cash flow from investing activities is higher than 54.09% of companies in Healthcare sector

High & Low

All-time High

$0.00
NNVC annual cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$324.30 K

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
NNVC previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
NNVC next annual earnings announcement has not yet been scheduled

OtherNNVCcash flowmetrics:

Annual CFF

$3.12 M
NNVC annual cash flow from financing activities is $3.12 million

Annual CFO

-$6.32 M
NNVC annual cash flow from operations is -$6.32 million

Annual FCF

-$6.47 M
NNVC annual free cash flow is -$6.47 million

Annual CAPEX

-
NNVC annual capital expenditures value is unknown

Quarterly CFI

-$46.80 K
+$51.40 K+52.34%

September 1, 2024

Summary

Performance

3-Month Change

+52.34%

1-Year Change

-4.93%

3-Year Change

-1700%

5-Year Change

-1700%

NNVC Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.2%
NNVC quarterly cash flow from investing activities is higher than 46.2% of companies in Healthcare sector

High & Low

All-time High

$749.20 K
NNVC quarterly cash flow from investing activities is currently -106.25% below its historical high of $749.20 thousand

3-Year Low

-$185.30 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NNVC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
NNVC next earnings announcement is scheduled for Feb 14, 2025

OtherNNVCcash flowmetrics:

Quarterly CFF

$1.71 M
NNVC quarterly cash flow from financing activities is $1.71 million

Quarterly CFO

-$2.59 M
NNVC quarterly cash flow from operations is -$2.59 million

Quarterly FCF

-$2.64 M
NNVC quarterly free cash flow is -$2.64 million

Quarterly CAPEX

-
NNVC quarterly capital expenditures value is unknown

TTM CFI

-$195.10 K
-$38.50 K-24.58%

September 1, 2024

Summary

Performance

3-Month Change

-24.58%

1-Year Change

-219.84%

3-Year Change

-28.61%

5-Year Change

-28.61%

NNVC TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.25%
NNVC TTM cash flow from investing activities is higher than 53.25% of companies in Healthcare sector

High & Low

All-time High

-$3200.00

3-Year Low

-$404.80 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NNVC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
NNVC next earnings announcement is scheduled for Feb 14, 2025

OtherNNVCcash flowmetrics:

TTM CFF

$4.83 M
NNVC TTM cash flow from financing activities is $4.83 million

TTM CFO

-$7.74 M
NNVC TTM cash flow from operations is -$7.74 million

TTM FCF

-$7.93 M
NNVC TTM free cash flow is -$7.93 million

TTM CAPEX

-
NNVC TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NNVC Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.2%-4.9%-219.8%
3 y3 years+34.4%-1700.0%-28.6%
5 y5 years-112.2%-1700.0%-28.6%

NNVC Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.2%+51.7%-1700.0%+74.7%-219.8%+51.8%
5 y5-year-1720.9%+51.7%<-9999.0%+74.7%-2168.6%+51.8%
alltimeall time<-9999.0%+97.3%-106.3%+99.0%-5996.9%+97.3%

NanoViricides Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$46.80 K(-52.3%)
-$195.10 K(+24.6%)
Jun 2024
-$156.60 K(+3.2%)
-$98.20 K(+120.2%)
-$156.60 K(+156.7%)
Mar 2024
-
-$44.60 K(+710.9%)
-$61.00 K(-19.4%)
Dec 2023
-
-$5500.00(-33.7%)
-$75.70 K(-34.5%)
Sep 2023
-
-$8300.00(+219.2%)
-$115.50 K(-23.9%)
Jun 2023
-$151.70 K(-53.2%)
-$2600.00(-95.6%)
-$151.70 K(-32.4%)
Mar 2023
-
-$59.30 K(+30.9%)
-$224.50 K(+9.8%)
Dec 2022
-
-$45.30 K(+1.8%)
-$204.50 K(-40.6%)
Sep 2022
-
-$44.50 K(-41.0%)
-$344.50 K(+6.2%)
Jun 2022
-$324.30 K(+35.8%)
-$75.40 K(+91.9%)
-$324.30 K(-2.8%)
Mar 2022
-
-$39.30 K(-78.8%)
-$333.50 K(-17.6%)
Dec 2021
-
-$185.30 K(+662.6%)
-$404.80 K(+77.5%)
Sep 2021
-
-$24.30 K(-71.3%)
-$228.10 K(-4.5%)
Jun 2021
-$238.80 K(+2676.7%)
-$84.60 K(-23.5%)
-$238.80 K(+50.5%)
Mar 2021
-
-$110.60 K(+1186.0%)
-$158.70 K(+229.9%)
Dec 2020
-
-$8600.00(-75.4%)
-$48.10 K(+21.8%)
Sep 2020
-
-$35.00 K(+677.8%)
-$39.50 K(+359.3%)
Jun 2020
-$8600.00(-88.3%)
-$4500.00(<-9900.0%)
-$8600.00(-37.7%)
Mar 2020
-
$0.00(0.0%)
-$13.80 K(-32.4%)
Dec 2019
-
$0.00(-100.0%)
-$20.40 K(-49.9%)
Sep 2019
-
-$4100.00(-57.7%)
-$40.70 K(-44.9%)
Jun 2019
-$73.80 K(-69.5%)
-$9700.00(+47.0%)
-$73.90 K(-8.5%)
Mar 2019
-
-$6600.00(-67.5%)
-$80.80 K(-60.9%)
Dec 2018
-
-$20.30 K(-45.6%)
-$206.90 K(-16.8%)
Sep 2018
-
-$37.30 K(+124.7%)
-$248.70 K(+2.9%)
Jun 2018
-$241.80 K(+46.5%)
-$16.60 K(-87.5%)
-$241.80 K(-11.0%)
Mar 2018
-
-$132.70 K(+113.7%)
-$271.60 K(+16.5%)
Dec 2017
-
-$62.10 K(+104.3%)
-$233.10 K(+36.3%)
Sep 2017
-
-$30.40 K(-34.5%)
-$171.00 K(+3.6%)
Jun 2017
-$165.00 K(-65.4%)
-$46.40 K(-50.7%)
-$165.00 K(-3.3%)
Mar 2017
-
-$94.20 K(<-9900.0%)
-$170.70 K(+24.3%)
Dec 2016
-
$0.00(-100.0%)
-$137.30 K(-17.8%)
Sep 2016
-
-$24.40 K(-53.2%)
-$167.10 K(-64.9%)
Jun 2016
-$476.40 K(-91.7%)
-$52.10 K(-14.3%)
-$476.40 K(-70.6%)
Mar 2016
-
-$60.80 K(+104.0%)
-$1.62 M(+100.0%)
Dec 2015
-
-$29.80 K(-91.1%)
-$810.30 K(-85.4%)
Sep 2015
-
-$333.70 K(-72.1%)
-$5.53 M(-4.0%)
DateAnnualQuarterlyTTM
Jun 2015
-$5.76 M(+10.1%)
-$1.20 M(-259.6%)
-$5.76 M(+11.3%)
Mar 2015
-
$749.20 K(-115.8%)
-$5.18 M(-28.0%)
Dec 2014
-
-$4.75 M(+744.6%)
-$7.19 M(+185.2%)
Sep 2014
-
-$562.50 K(-8.2%)
-$2.52 M(-51.8%)
Jun 2014
-$5.23 M(+391.2%)
-$612.90 K(-51.4%)
-$5.23 M(+11.7%)
Mar 2014
-
-$1.26 M(+1400.2%)
-$4.68 M(+5.9%)
Dec 2013
-
-$84.00 K(-97.4%)
-$4.42 M(+1.9%)
Sep 2013
-
-$3.27 M(+4944.7%)
-$4.34 M(+307.4%)
Jun 2013
-$1.06 M(+1717.2%)
-$64.90 K(-93.5%)
-$1.06 M(+6.5%)
Mar 2013
-
-$1.00 M(<-9900.0%)
-$1.00 M(+8828.6%)
Dec 2012
-
$0.00(0.0%)
-$11.20 K(-62.0%)
Sep 2012
-
$0.00(0.0%)
-$29.50 K(-49.7%)
Jun 2012
-$58.60 K(-69.8%)
$0.00(-100.0%)
-$58.60 K(-28.4%)
Mar 2012
-
-$11.20 K(-38.8%)
-$81.90 K(-30.0%)
Dec 2011
-
-$18.30 K(-37.1%)
-$117.00 K(+18.5%)
Sep 2011
-
-$29.10 K(+24.9%)
-$98.70 K(-49.1%)
Jun 2011
-$194.00 K(-74.0%)
-$23.30 K(-49.7%)
-$194.10 K(-67.2%)
Mar 2011
-
-$46.30 K(<-9900.0%)
-$592.30 K(+1.1%)
Dec 2010
-
$0.00(-100.0%)
-$585.80 K(-28.1%)
Sep 2010
-
-$124.50 K(-70.5%)
-$814.30 K(+9.3%)
Jun 2010
-$744.80 K(+10.7%)
-$421.50 K(+959.0%)
-$744.80 K(+163.6%)
Mar 2010
-
-$39.80 K(-82.6%)
-$282.50 K(-22.4%)
Dec 2009
-
-$228.50 K(+315.5%)
-$363.90 K(+17.5%)
Sep 2009
-
-$55.00 K(-234.8%)
-$309.70 K(-54.0%)
Jun 2009
-$672.80 K(+564.8%)
$40.80 K(-133.7%)
-$672.90 K(-13.1%)
Mar 2009
-
-$121.20 K(-30.5%)
-$774.70 K(+12.6%)
Dec 2008
-
-$174.30 K(-58.3%)
-$687.80 K(+32.4%)
Sep 2008
-
-$418.20 K(+585.6%)
-$519.40 K(+413.2%)
Jun 2008
-$101.20 K(-19.8%)
-$61.00 K(+77.8%)
-$101.20 K(-28.8%)
Mar 2008
-
-$34.30 K(+481.4%)
-$142.20 K(+22.0%)
Dec 2007
-
-$5900.00(<-9900.0%)
-$116.60 K(-5.2%)
Sep 2007
-
$0.00(-100.0%)
-$123.00 K(-2.5%)
Jun 2007
-$126.20 K(+5909.5%)
-$102.00 K(+1072.4%)
-$126.20 K(+421.5%)
Mar 2007
-
-$8700.00(-29.3%)
-$24.20 K(+56.1%)
Dec 2006
-
-$12.30 K(+284.4%)
-$15.50 K(+384.4%)
Sep 2006
-
-$3200.00
-$3200.00
Jun 2006
-$2100.00(<-9900.0%)
-
-
Jun 2005
$0.00
-
-

FAQ

  • What is NanoViricides annual cash flow from investing activities?
  • What is the all time high annual CFI for NanoViricides?
  • What is NanoViricides annual CFI year-on-year change?
  • What is NanoViricides quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for NanoViricides?
  • What is NanoViricides quarterly CFI year-on-year change?
  • What is NanoViricides TTM cash flow from investing activities?
  • What is the all time high TTM CFI for NanoViricides?
  • What is NanoViricides TTM CFI year-on-year change?

What is NanoViricides annual cash flow from investing activities?

The current annual CFI of NNVC is -$156.60 K

What is the all time high annual CFI for NanoViricides?

NanoViricides all-time high annual cash flow from investing activities is $0.00

What is NanoViricides annual CFI year-on-year change?

Over the past year, NNVC annual cash flow from investing activities has changed by -$4900.00 (-3.23%)

What is NanoViricides quarterly cash flow from investing activities?

The current quarterly CFI of NNVC is -$46.80 K

What is the all time high quarterly CFI for NanoViricides?

NanoViricides all-time high quarterly cash flow from investing activities is $749.20 K

What is NanoViricides quarterly CFI year-on-year change?

Over the past year, NNVC quarterly cash flow from investing activities has changed by -$2200.00 (-4.93%)

What is NanoViricides TTM cash flow from investing activities?

The current TTM CFI of NNVC is -$195.10 K

What is the all time high TTM CFI for NanoViricides?

NanoViricides all-time high TTM cash flow from investing activities is -$3200.00

What is NanoViricides TTM CFI year-on-year change?

Over the past year, NNVC TTM cash flow from investing activities has changed by -$134.10 K (-219.84%)